{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:30:32Z","timestamp":1784993432948,"version":"3.55.0"},"reference-count":94,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,25]]},"DOI":"10.18632\/oncotarget.12209","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T16:21:48Z","timestamp":1474647708000},"page":"70715-70737","source":"Crossref","is-referenced-by-count":63,"title":["Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Renata","family":"Colla","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Izzotti","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Genova, Genova, Italy"},{"name":"IRCCS AOU San Martino IST Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"De Ciucis","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Fenoglio","sequence":"additional","affiliation":[{"name":"Center of Excellence for Biomedical Research, Department of Internal Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ravera","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Speciale","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ricciarelli","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lisa","family":"Furfaro","sequence":"additional","affiliation":[{"name":"Giannina Gaslini Institute, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pulliero","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Passalacqua","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Traverso","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adelaide","family":"Pronzato","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Domenicotti","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Marengo","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1517\/14728222.2014.867946","article-title":"Therapeutic targets for neuroblastomas","volume":"18","author":"Kolla","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"2","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Dyer","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Cohn","year":"2007","journal-title":"Lancet"},{"key":"5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1126\/science.6719137","article-title":"Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage","volume":"224","author":"Bishop","year":"1984","journal-title":"Science"},{"key":"6","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","article-title":"Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas","volume":"313","author":"Hammond","year":"1985","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1470-2045(08)70069-X","article-title":"High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial","volume":"9","author":"Machin","year":"2008","journal-title":"Lancet Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1200\/JCO.2007.13.8925","article-title":"Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study","volume":"27","author":"Villablanca","year":"2009","journal-title":"J Clin Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid","volume":"341","author":"Reynolds","year":"1999","journal-title":"Children's Cancer Group. N Engl J Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1002\/cncr.11797","article-title":"A phase II study of topotecan with vincristine and doxorubicin in children with recurrent\/refractory neuroblastoma","volume":"98","author":"De Bernardi","year":"2003","journal-title":"Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00432-007-0216-y","article-title":"Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial","volume":"133","author":"Hero","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/MPH.0b013e3180320b48","article-title":"Topotecan and etoposide in the treatment of relapsed high-risk neuroblastoma: results of a phase 2 trial","volume":"29","author":"Hero","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/10428190109057981","article-title":"Therapy related leukemias: susceptibility, prevention and treatment","volume":"41","author":"Pagano","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<9::AID-IJC3>3.0.CO;2-Y","article-title":"Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations","volume":"71","author":"Tucker","year":"1997","journal-title":"Int J Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jcb.10219","article-title":"Role of GST P1-1 in mediating the effect of etoposide on human neuroblastoma cell line Sh-Sy5y","volume":"86","author":"Federici","year":"2002","journal-title":"J Cell Biochem"},{"key":"16","doi-asserted-by":"publisher","first-page":"972913","DOI":"10.1155\/2013\/972913","article-title":"Role of glutathione in cancer progression and chemoresistance","author":"Domenicotti","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"17","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1038\/cddis.2011.34","article-title":"Oxidative stress and ERK1\/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR","volume":"2","author":"Stiuso","year":"2011","journal-title":"Cell Death Dis"},{"key":"18","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1158\/1078-0432.CCR-03-0309","article-title":"Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53","volume":"10","author":"Pahlman","year":"2004","journal-title":"Clin Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0305-7372(02)00109-3","article-title":"Clinical and cellular pharmacology in relation to solid tumours of childhood","volume":"29","author":"Veal","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbabio.2004.09.004","article-title":"P\/O ratios of mitochondrial oxidative phosphorylation","volume":"1706","author":"Hinkle","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"21","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.2174\/138161206777585193","article-title":"Molecularly guided therapy of neuroblastoma: a review of different approaches","volume":"12","author":"Pistoia","year":"2006","journal-title":"Curr Pharm Des"},{"key":"22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ijc.2910510511","article-title":"Modulation of neuroblastoma cell differentiation by the extracellular matrix","volume":"51","author":"Bogenmann","year":"1992","journal-title":"Int J Cancer"},{"key":"23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/pmic.200401147","article-title":"A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines","volume":"5","author":"Federici","year":"2005","journal-title":"Proteomics"},{"key":"24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/jnci\/86.10.780","article-title":"Hsp27 expression in neuroblastoma: correlation with disease stage","volume":"86","author":"Hanash","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/1471-2407-10-473","article-title":"p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma","volume":"10","author":"Amor-Gueret","year":"2010","journal-title":"BMC Cancer"},{"key":"26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1158\/0008-5472.CAN-12-1739","article-title":"Inhibiting interactions of lysine demethylase LSD1 with snail\/slug blocks cancer cell invasion","volume":"73","author":"Colombo","year":"2013","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1200\/JCO.1998.16.6.2007","article-title":"Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study","volume":"16","author":"Castleberry","year":"1998","journal-title":"J Clin Oncol"},{"key":"28","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.1999.17.7.2264","article-title":"Molecular biology of neuroblastoma","volume":"17","author":"Matthay","year":"1999","journal-title":"J Clin Oncol"},{"key":"29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3835(03)00101-0","article-title":"The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis","volume":"197","author":"Versteeg","year":"2003","journal-title":"Cancer Lett"},{"key":"30","doi-asserted-by":"publisher","first-page":"8819","DOI":"10.1200\/JCO.2004.00.2931","article-title":"Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy","volume":"23","author":"Bowman","year":"2005","journal-title":"J Clin Oncol"},{"key":"31","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.bcp.2008.06.024","article-title":"Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation","volume":"76","author":"Elmore","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"32","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.459","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Kroemer","year":"2012","journal-title":"Oncogene"},{"key":"33","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/carcin\/bgq064","article-title":"Homologous recombination in cancer development, treatment and development of drug resistance","volume":"31","author":"Helleday","year":"2010","journal-title":"Carcinogenesis"},{"key":"34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejphar.2009.05.032","article-title":"Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy","volume":"625","author":"Wlodkowic","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Gottesman","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"36","first-page":"5396","article-title":"Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy","volume":"58","author":"Reynolds","year":"1998","journal-title":"Cancer Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/08880010701451343","article-title":"Pharmacokinetics of doxorubicin and etoposide in a morbidly obese pediatric patient","volume":"24","author":"Eksborg","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10715769900300851","article-title":"Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress","volume":"31","author":"McLellan","year":"1999","journal-title":"Free Radic Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1042\/BJ20070186","article-title":"Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells","volume":"406","author":"Liu","year":"2007","journal-title":"Biochem J"},{"key":"40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.cdd.4400512","article-title":"Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells","volume":"6","author":"Debatin","year":"1999","journal-title":"Cell Death Differ"},{"key":"41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.26306","article-title":"Genetic determinants of oxidative stress-mediated sensitization of drug-resistant cancer cells","volume":"130","author":"Maiti","year":"2012","journal-title":"Int J Cancer"},{"key":"42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/tpj.2009.49","article-title":"Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells","volume":"10","author":"Maiti","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"43","doi-asserted-by":"publisher","first-page":"e24665","DOI":"10.1371\/journal.pone.0024665","article-title":"Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production","volume":"6","author":"Griguer","year":"2011","journal-title":"PLoS One"},{"key":"44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Huang","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"45","doi-asserted-by":"publisher","first-page":"37813","DOI":"10.1074\/jbc.M110.200675","article-title":"Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species","volume":"286","author":"Pillai","year":"2011","journal-title":"J Biol Chem"},{"key":"46","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ijc.24822","article-title":"CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients","volume":"126","author":"Herr","year":"2010","journal-title":"Int J Cancer"},{"key":"47","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1093\/carcin\/13.11.1947","article-title":"Expression of topoisomerase II, catalase, metallothionein and thymidylate-synthase in human squamous cell lung carcinomas and their correlation with doxorubicin resistance and with patients' smoking habits","volume":"13","author":"Mattern","year":"1992","journal-title":"Carcinogenesis"},{"key":"48","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3892\/etm.2012.487","article-title":"Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance","volume":"3","author":"Briehl","year":"2012","journal-title":"Exp Ther Med"},{"key":"49","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bcp.2011.11.016","article-title":"The role of glutathione in brain tumor drug resistance","volume":"83","author":"Reigan","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"50","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","article-title":"The role of glutathione-S-transferase in anti-cancer drug resistance","volume":"22","author":"Tew","year":"2003","journal-title":"Oncogene"},{"key":"51","first-page":"5373","article-title":"Cyclophosphamide resistance in medulloblastoma","volume":"52","author":"Griffith","year":"1992","journal-title":"Cancer Res"},{"key":"52","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","article-title":"Glutathione","volume":"52","author":"Anderson","year":"1983","journal-title":"Annu Rev Biochem"},{"key":"53","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00726-014-1687-1","article-title":"Upregulation of capacity for glutathione synthesis in response to amino acid deprivation: regulation of glutamate-cysteine ligase subunits","author":"Stipanuk","journal-title":"Amino Acids"},{"key":"54","first-page":"5954","article-title":"Decreased DNA interstrand cross-linking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione","volume":"49","author":"Gray","year":"1989","journal-title":"Cancer Res"},{"key":"55","first-page":"2525","article-title":"Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard","volume":"47","author":"Smith","year":"1987","journal-title":"Cancer Res"},{"key":"56","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/cncr.20571","article-title":"Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha (GST)-alpha, GST-mu, and GST-pi","volume":"101","author":"Salmon","year":"2004","journal-title":"Cancer"},{"key":"57","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.leukres.2013.10.010","article-title":"The aryl hydrocarbon receptor nuclear translocator (ARNT) modulates the antioxidant response in AML cells","volume":"37","author":"Wells","year":"2013","journal-title":"Leuk Res"},{"key":"58","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/toxsci\/kfl147","article-title":"Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate","volume":"96","author":"Lampen","year":"2007","journal-title":"Toxicol Sci"},{"key":"59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/toxsci\/kfp079","article-title":"Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes","volume":"110","author":"Hankinson","year":"2009","journal-title":"Toxicol Sci"},{"key":"60","doi-asserted-by":"publisher","first-page":"16582","DOI":"10.1074\/jbc.M109.090506","article-title":"Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2","volume":"285","author":"Day","year":"2010","journal-title":"J Biol Chem"},{"key":"61","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1182\/blood.V99.2.641","article-title":"P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin","volume":"99","author":"Fais","year":"2002","journal-title":"Blood"},{"key":"62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ccr.2004.06.026","article-title":"Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells","volume":"6","author":"Gottesman","year":"2004","journal-title":"Cancer Cell"},{"key":"63","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.bbabio.2009.02.009","article-title":"Mitochondrial ABC proteins in health and disease","volume":"1787","author":"Tampe","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"64","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.freeradbiomed.2011.06.019","article-title":"Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids","volume":"51","author":"Tytgat","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"65","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0891-5849(03)00332-0","article-title":"Role of PKC-delta activity in glutathione-depleted neuroblastoma cells","volume":"35","author":"Marinari","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3892\/ijo.32.1.121","article-title":"GSH loss per se does not affect neuroblastoma survival and is not genotoxic","volume":"32","author":"Domenicotti","year":"2008","journal-title":"Int J Oncol"},{"key":"67","doi-asserted-by":"publisher","first-page":"e14661","DOI":"10.1371\/journal.pone.0014661","article-title":"PKCdelta sensitizes neuroblastoma cells to L-buthionine-sulfoximine and etoposide inducing reactive oxygen species overproduction and DNA damage","volume":"6","author":"Domenicotti","year":"2011","journal-title":"PLoS One"},{"key":"68","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.freeradbiomed.2011.11.007","article-title":"Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1","volume":"52","author":"Traverso","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"69","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/S0959-8049(97)00203-7","article-title":"Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines","volume":"33","author":"Reynolds","year":"1997","journal-title":"Eur J Cancer"},{"key":"70","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/1097-0142(19901015)","article-title":"Multidrug resistance in ovarian cancer","volume":"60","author":"Ozols","year":"1987","journal-title":"Cancer"},{"key":"71","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1038\/onc.2014.338","article-title":"Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death","volume":"30","author":"Fulda","year":"2015","journal-title":"Oncogene"},{"key":"72","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.freeradbiomed.2011.10.493","article-title":"Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress","volume":"52","author":"Spitz","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"73","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1158\/1078-0432.CCR-11-0736","article-title":"Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism","volume":"17","author":"Spitz","year":"2011","journal-title":"Clin Cancer Res"},{"key":"74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14653240600735834","article-title":"Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells","volume":"8","author":"Saccardi","year":"2006","journal-title":"Cytotherapy"},{"key":"75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4161\/cc.23050","article-title":"Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt","volume":"12","author":"Filaci","year":"2013","journal-title":"Cell Cycle"},{"key":"76","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0022-1759(99)00136-2","article-title":"A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens","volume":"230","author":"Wallace","year":"1999","journal-title":"J Immunol Methods"},{"key":"77","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1038\/cddis.2013.118","article-title":"p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment","volume":"4","author":"Domenicotti","year":"2013","journal-title":"Cell Death Dis"},{"key":"78","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0006-2952(87)90362-5","article-title":"In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins","volume":"36","author":"Sinha","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"79","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1006\/taap.1995.1070","article-title":"Phenoxyl radicals of etoposide (VP-16) can directly oxidize intracellular thiols: protective versus damaging effects of phenolic antioxidants","volume":"131","author":"Kagan","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"key":"80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2015.10.026","article-title":"A simple dried blood spot method for clinical pharmacological analyses of etoposide in cancer patients using liquid chromatography and fluorescence detection","volume":"452","author":"Vovk","year":"2016","journal-title":"Clin Chim Acta"},{"key":"81","doi-asserted-by":"publisher","first-page":"11806","DOI":"10.18632\/oncotarget.3688","article-title":"Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models","volume":"6","author":"Pistoia","year":"2015","journal-title":"Oncotarget"},{"key":"82","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12013-010-9112-1","article-title":"Characterization of Myelin Sheath F(o)F(1)-ATP synthase and its regulation by IF(1)","volume":"59","author":"Morelli","year":"2011","journal-title":"Cell Biochem Biophys"},{"key":"83","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1096\/fj.11-192088","article-title":"Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells","volume":"26","author":"Maggi","year":"2012","journal-title":"Faseb J"},{"key":"84","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0003-2697(80)90314-0","article-title":"Spectrophotometric assay for D-(-)-lactate in plasma","volume":"102","author":"Bloch","year":"1980","journal-title":"Anal Biochem"},{"key":"85","volume-title":"In Method of Enzymatic Analysis","volume":"2","author":"Bergmeyer","year":"1983","edition":"3"},{"key":"86","doi-asserted-by":"publisher","first-page":"e20110","DOI":"10.1371\/journal.pone.0020110","article-title":"Trabecular meshwork gene expression after selective laser trabeculoplasty","volume":"6","author":"Sacca","year":"2011","journal-title":"PLoS One"},{"key":"87","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1750-3639.2008.00229.x","article-title":"Interferon-related transcriptome alterations in the cerebrospinal fluid cells of Aicardi-Goutieres patients","volume":"19","author":"Fazzi","year":"2009","journal-title":"Brain Pathol"},{"key":"88","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3892\/or_00000756","article-title":"DNA oxidative damage of neoplastic rat liver lesions","volume":"23","author":"Domenicotti","year":"2010","journal-title":"Oncol Rep"},{"key":"89","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/carcin\/10.6.1099","article-title":"Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus","volume":"10","author":"Millman","year":"1989","journal-title":"Carcinogenesis"},{"key":"90","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3109\/10715762.2015.1050962","article-title":"Oxidative stress in myelin sheath: The other face of the extramitochondrial oxidative phosphorylation ability","volume":"49","author":"Panfoli","year":"2015","journal-title":"Free Radic Res"},{"key":"91","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1038\/bcj.2016.73","article-title":"Pim2 is important for regulating DNA damage response in multiple myeloma cells","volume":"6","author":"Raje","year":"2016","journal-title":"Blood Cancer J"},{"key":"92","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1038\/ncomms6426","article-title":"Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength","volume":"5","author":"Miyagawa","year":"2014","journal-title":"Nature Commun"},{"key":"93","doi-asserted-by":"publisher","first-page":"42590","DOI":"10.18632\/oncotarget.6052","article-title":"The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications","volume":"6","author":"Ren","year":"2015","journal-title":"Oncotarget"},{"key":"94","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.dnarep.2016.04.003","article-title":"Interaction between APC and FEN1 during breast carcinogenesis","volume":"41","author":"Hromas","year":"2016","journal-title":"DNA Repair"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T14:22:17Z","timestamp":1589293337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":94,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2016,10,25]]}},"alternative-id":["12209","27683112"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12209","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]}}}